Aimfinity Investment Corp. I extended its deadline to complete an initial business combination from November 28, 2025 to December 28, 2025 by depositing $500 into its Trust Account.

The press release reiterates a long-standing merger plan with Docter under a 2023 merger agreement, detailing reincorporation and acquisition mergers, and directs readers to the proxy statement/prospectus and SEC filings for full information.

I-Fa Chang, the sponsor’s manager, deposited the extension payment into the Trust Account on November 28, 2025.

This marks the second of nine monthly extensions available under the company’s amended and restated charter, with extensions permissible monthly through late July 2026 or sooner at the board’s discretion.

Aimfinity Investment Corp. I is a Cayman Islands exempted SPAC aiming to merge with high-growth businesses and take them to the capital markets.

Investors are urged to review the Final Prospectus and related materials when available, as they contain important information about AIMA, Docter, and the proposed transactions.

The press release contains forward-looking statements about the proposed transaction, including expected enterprise values, synergies, and timing, and notes risks and uncertainties that could cause actual results to differ.

The press release provides contact details for CEO I-Fa Chang, including mailing address and email.

Shareholders were previously advised to read the proxy statement/prospectus and amendments, with materials mailed to those of record as of February 25, 2025; additional copies are available from the SEC or the company.